|
International
collaboration
SAAVI
is a highly integrated part of the worldwide
drive to develop an HIV/AIDS
vaccine, and enjoys close collaboration with
many other global players in the field, including
organisations such as the US National Institutes
of Health (NIH), the NIH-funded HIV Vaccine
Trials Network (HVTN), the International AIDS
Vaccine Initiative (IAVI), the European Union
(EU), the African AIDS Vaccine Programme (AAVP),
the European Developing Country Trial Platform
(EDCTP), the Ethiopian AIDS Vaccine Initiative
(EAVI), the Nigerian AIDS Vaccine Programme
(NAVP) and the Botswana Harvard AIDS Institute,
as well as international companies such as
Cobra, Therion, Merck, Chiron, Large Scale
Biology Corporation and Microscience.
International collaboration is essential
to fast track the development of an HIV/AIDS
vaccine for South Africa and the rest
of the world, and SAAVI values these collaborative
ventures. Although closely collaborating
with these and other organisations, SAAVI
operates independently allowing it to pursue
its own specific goals and maintain its focus
on the needs of the southern African region. |
|
About
Funding
Capacity development
International
collaboration
|
